Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Diclofenac sodium
Thea Pharmaceuticals Ltd
S01BC03
Diclofenac sodium
1mg/1ml
Eye drops
Ocular
No Controlled Drug Status
Valid as a prescribable product
BNF: 11080200; GTIN: 4891572090034
00000000 VOLTAROL ® OPHTHA MULTIDOSE 0.1% EYE DROPS (DICLOFENAC SODIUM) PATIENT INFORMATION LEAFLET Your doctor has decided that you need these eye drops to help treat your condition. PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TO USE THE EYE DROPS. IT CONTAINS IMPORTANT INFORMATION. Keep the leaflet in a safe place because you may want to read it again. If you have any other questions, or if there is something you don’t understand, please ask your doctor or pharmacist. This medicine has been prescribed for you. Never give it to someone else. It may not be the right medicine for them even if their symptoms seem to be the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. The eye drops will be referred to as Voltarol Ophtha in this leaflet. IN THIS LEAFLET: 1. What Voltarol Ophtha are and what they are used for 2. Things to consider before you start to use Voltarol Ophtha 3. How to use Voltarol Ophtha 4. Possible side effects 5. How to store Voltarol Ophtha 6. Further information 1. WHAT VOLTAROL OPHTHA ARE AND WHAT THEY ARE USED FOR Voltarol Ophtha contain 0.1% of the active ingredient diclofenac sodium. Diclofenac sodium is one of a group of medicines called non-steroidal anti- inflammatory drugs (NSAIDs). NSAIDs reduce pain and inflammation. Voltarol Ophtha are used • before eye surgery, to help keep the pupil open during surgery, or • after eye surgery or injury, to control pain and/or inflammation, • to reduce the symptoms, such as red, runny or itchy eyes associated with seasonal allergic conjunctivitis (hayfever). 2. THINGS TO CONSIDER BEFORE YOU START TO USE VOLTAROL OPHTHA SOME PEOPLE MUST NOT HAVE VOLTAROL OPHTHA. TALK TO YOUR DOCTOR IF: • you think you may be allergic to diclofenac sodium, aspirin or any other NSAIDs, or to any of the other ingredients of the eye drops. (These are listed at the end of the leaflet.) • You are more than 6 months pregnant. YOU SHOULD ALSO ASK YOURS Read the complete document
OBJECT 1 VOLTAROL OPHTHA MULTIDOSE Summary of Product Characteristics Updated 26-Feb-2015 | Thea Pharmaceuticals Ltd 1. Name of the medicinal product Voltarol Ophtha Multidose 0.1% Eye Drops 2. Qualitative and quantitative composition Contains diclofenac sodium 1mg/ml 3. Pharmaceutical form Eye drops solution 4. Clinical particulars 4.1 Therapeutic indications i. Inhibition of peroperative miosis during cataract surgery (Voltarol Ophtha Multidose has no intrinsic mydriatic properties and does not replace standard mydriatic agents). ii. Treatment of post-operative inflammation in cataract surgery. iii. Control of ocular pain and discomfort associated with corneal epithelial defects after excimer PRK surgery or accidental non-penetrating trauma. iv. Control of inflammation after Argon Laser Trabeculoplasty (ALT). v. The relief of the ocular signs and symptoms of Seasonal Allergic Conjunctivitis (SAC). vi. Treatment of inflammation and discomfort after strabismus surgery vii. Treatment of ocular pain and discomfort after radial keratotomy 4.2 Posology and method of administration Voltarol Ophtha eye drop solution is for instillation into the conjunctival sac only. It should never be injected subconjunctivally, nor should it be directly introduced into the anterior chamber of the eye. ADULTS: Prophylaxis of preoperative miosis Apply 1 drop four times during the 2 hours before surgery. Control of post-operative inflammation Apply 1 drop 4 times daily for up to 28 days. Control of Post-PRK pain and discomfort Apply 1 drop 2 times in the hour prior to surgery, 1 drop 2 times five minutes apart immediately after PRK surgery and then post-operatively 1 drop every 2-5 hours while awake for up to 24 hours. Control of ocular pain associated with corneal epithelial defects after accidental non-penetrating trauma. Apply 1 drop 4 times daily for up to 2 days. Control of post-ALT inflammation. Apply one drop 4 times during the 2 hours before ALT, and then one drop 4 times daily for up to 7 days. The relief of the ocular signs an Read the complete document